BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32821381)

  • 1. Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review.
    Acharya Y; Sayed A
    Ther Adv Infect Dis; 2020; 7():2049936120947517. PubMed ID: 32821381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
    de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
    Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
    Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review.
    Saghir SAM; AlGabri NA; Alagawany MM; Attia YA; Alyileili SR; Elnesr SS; Shafi ME; Al-Shargi OYA; Al-Balagi N; Alwajeeh AS; Alsalahi OSA; Patra AK; Khafaga AF; Negida A; Noreldin A; Al-Amarat W; Almaiman AA; El-Tarabily KA; Abd El-Hack ME
    Ther Clin Risk Manag; 2021; 17():371-387. PubMed ID: 33953559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
    Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
    Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
    Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis.
    Agstam S; Yadav A; Kumar-M P; Gupta A
    Indian Pacing Electrophysiol J; 2021; 21(1):36-43. PubMed ID: 33075484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
    Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
    Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19.
    Zhanel GG; Zhanel MA; Boreskie KF; Lynch JP; Karlowsky JA
    Can J Infect Dis Med Microbiol; 2021; 2021():5942366. PubMed ID: 34557260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Chloroquine and Hydroxychloroquine on ACE2-Related Coronavirus Pathology and the Cardiovascular System: An Evidence-Based Review.
    Chen L; Chen H; Dong S; Huang W; Chen L; Wei Y; Shi L; Li J; Zhu F; Zhu Z; Wang Y; Lv X; Yu X; Li H; Wei W; Zhang K; Zhu L; Qu C; Hong J; Hu C; Dong J; Qi R; Lu D; Wang H; Peng S; Hao G
    Function (Oxf); 2020; 1(2):zqaa012. PubMed ID: 38626250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
    De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
    Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine.
    Bakadia BM; He F; Souho T; Lamboni L; Ullah MW; Boni BO; Ahmed AAQ; Mukole BM; Yang G
    Biomed Pharmacother; 2021 Jan; 133():111008. PubMed ID: 33227708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19.
    Mittal N; Mittal R; Gupta MC; Kaushal J; Chugh A; Khera D; Singh S
    J Family Med Prim Care; 2021 Jun; 10(6):2126-2139. PubMed ID: 34322403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
    Rouamba T; Ouédraogo E; Barry H; Yaméogo NV; Sondo A; Boly R; Zoungrana J; Ouédraogo AR; Tahita MC; Poda A; Diendéré AE; Ouedraogo AS; Valea I; Traoré I; Tarnagda Z; Drabo MK; Tinto H;
    Int J Infect Dis; 2022 May; 118():224-229. PubMed ID: 35227869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
    Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C
    BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.
    Kapuy O; Korcsmáros T
    PLoS One; 2022; 17(4):e0266337. PubMed ID: 35390060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
    Fu J; Jia Q; Zhou H; Zhang L; Wang S; Liang P; Lv Y; Han S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122469. PubMed ID: 33310480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).
    Zhao Y; Zhang J; Zheng K; Thai S; Simpson RJ; Kinlaw AC; Xu Y; Wei J; Cui X; Buse JB; Stürmer T; Wang T
    Drugs Real World Outcomes; 2022 Jun; 9(2):231-241. PubMed ID: 35386046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety.
    Takla M; Jeevaratnam K
    Saudi Pharm J; 2020 Dec; 28(12):1760-1776. PubMed ID: 33204210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19.
    Klouda CB; Stone WL
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.